Skip to main content

Advertisement

SpringerLink
Log in

Aberrant Expression of Calretinin, D2–40 and Mesothelin in Mucinous and Non-Mucinous Colorectal Carcinomas and Relation to Clinicopathological Features and Prognosis

  • Original Article
  • Published:
Pathology & Oncology Research

Abstract

CRC is a heterogeneous disease in terms of morphology, invasive behavior, metastatic capacity, and clinical outcome. Recently, many so-called mesothelial markers, including calretinin, D2–40, WT1, thrombomodulin, mesothelin, and others, have been certified. The aim of this study was to assess the immunohistochemical expression of calretinin and other mesothelial markers (D2–40 and mesothelin) in colorectal mucinous adenocarcinoma (MA) and non mucinous adenocarcinoma (NMA) specimens and relation to clinicopathological features and prognosis using manual tissue microarray technique. We studied tumor tissue specimens from 150 patients with colorectal MA and NMA who underwent radical surgery from January 2007 to January 2012. High-density manual tissue microarrays were constructed using a modified mechanical pencil tip technique, and paraffin sections were submitted for immunohistochemistry using Calretinin, D2–40 and mesothelin expressions. We found that NMA showed significantly more calretinin and D2–40 expression than MA In contrast, no statistically significant difference between NMA and MA was detected in mesothelin expression. There were no statistically significant relations between any of the clinicopathological or histological parameters and any of the three markers. In a univariate analysis, neither calretinin nor D2–40 expressions showed any significant relations to DFS or OS. However, mesothelin luminal expression was significantly associated with worse DFS. Multivariate Cox regression analysis proved that luminal mesothelin expression was an independent negative prognostic factor in NMA. In conclusion, Calretinin, D2–40 and mesothelin are aberrantly expressed in a proportion of CRC cases with more expression in NMA than MA. Aberrant expression of these mesothelial markers was not associated with clinicopathological or histological features of CRCs. Only mesothelin expression appears to be a strong predictor of adverse prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ferlay J, Soerjomataram I, Ervik M, et al.: GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer 2013. http://globocan.iarc.fr. Accessed on 23 May 2015.

  2. Foda AA, El-Hawary AK, Abdel-Aziz A (2013) Differential expression of matrix metalloproteinase- 13 in mucinous and nonmucinous colorectal carcinomas. Ann Diagn Pathol 17:347–353

    Article  PubMed  Google Scholar 

  3. Hamilton SR, Bosman FT, Boffetta P, et al. (2010) Tumors of the colon and rectum. In: Bosman FT, Carneiro F, Hruban RH, et al. (eds) WHO Classification of tumors of the digestive system. IARCPress, Lyon, pp. 132–182

    Google Scholar 

  4. Mekenkamp JM, Heesterbeek KJ, Koopman M, et (2012) Mucinous adenocarcinomas: Poor prognosis in metastatic colorectal cancer. Eur J Cancer, 48: 501–509.

  5. Ordonez NG (2005) D2–40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma. Hum Pathol 205:372–380

    Article  Google Scholar 

  6. Ordonez NG (2006) Value of immunohistochemistry in distinguishing peritoneal mesothelioma from serous carcinoma of the ovary and peritoneum: a review and update. Adv Anat Pathol 13:16–25

    Article  CAS  PubMed  Google Scholar 

  7. Rogers JH (1987) Calretinin: a gene for a novel calcium-binding protein expressed principally in neurons. J Cell Biol 105:1343–1353

    Article  CAS  PubMed  Google Scholar 

  8. Gander JC, Gotzos V, Fellay B, et al. (1996) Inhibition of the proliferative cycle and apoptotic events in WiDr cells after down-regulation of the calcium-binding protein calretinin using antisense oligodeoxynucleotides. Exp Cell Res 225:399–410

    Article  CAS  PubMed  Google Scholar 

  9. Miettinen M, Limon J, Niezabitowski A, et al. (2001) Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma. Am J Surg Pathol 25:610–617

    Article  CAS  PubMed  Google Scholar 

  10. Lugli A, Forster Y, Haas P, et al. (2003) Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissue samples. Hum Pathol. 34:994–1000

    Article  CAS  PubMed  Google Scholar 

  11. Dent R, Hanna WM, Trudeau M, et al. (2009) Pattern of metastatic spread in triple-negative breast cancer. Breast Cancer Res Treat 115:423–428

    Article  PubMed  Google Scholar 

  12. Winn B, Tavares R, Fanion J, et al. (2009) Differentiating the undifferentiated: immunohistochemical profile of medullary carcinoma of the colon with an emphasis on intestinal differentiation. Hum Pathol 40:398–404

    Article  CAS  PubMed  Google Scholar 

  13. Chu AU, Litzky LA, Pasha TL, et al. (2005) Utility of D2–40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod Pathol 18:105–110

    Article  CAS  PubMed  Google Scholar 

  14. Chang K, Pastan I (1994) Molecular cloning and expression of a cDNA encoding a protein detected by the K1 antibody from an ovarian carcinoma (OVCAR-3) cell line. Int J Cancer 57:90–97

    Article  CAS  PubMed  Google Scholar 

  15. Ordonez NG (2003) Application of mesothelin immunostaining in tumor diagnosis. Am J Surg Pathol 27:1418–1428

    Article  PubMed  Google Scholar 

  16. Cheng YW, Idrees K, Shattock R, et al. (2010) Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer. Int J Cancer 127:568–577

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Li H, Zhao P, Lu Y (2012) Correlation of aberrant expression of CD133 with FHIT and malignant phenotype of colorectal adenocarcinoma. Int J Colorectal Dis 27:1015–1020

    Article  PubMed  Google Scholar 

  18. Lee SJ, Choi SY, Kim WJ, et al. (2013) Combined aberrant expression of E-cadherin and S100 A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients. Diagn Pathol 19(8):99

    Article  Google Scholar 

  19. Foda AA (2013) No-cost manual method for preparation of tissue microarrays having high quality comparable to semiautomated methods. Appl Immunohistochem Mol Morphol 21:271–274

    CAS  PubMed  Google Scholar 

  20. Takeshima Y, Amatya VJ, Kushitani K, et al. (2008) A Useful antibody panel for differential diagnosis between peritoneal mesothelioma and ovarian serous carcinoma in japanese cases. Am J Clin Pathol 130:771–779

    Article  CAS  PubMed  Google Scholar 

  21. Ordóñez NG (2003) Value of mesothelin immunostaining in the diagnosis of mesothelioma. Mod Pathol 16(3):192–197

    Article  PubMed  Google Scholar 

  22. Hanna A, Pang Y, Bedrossian CW, et al. (2010) Podoplanin is a useful marker for identifying mesothelioma in malignant effusions. Diagn Cytopathol 38(4):264–269

    PubMed  Google Scholar 

  23. Cargnello R, Celio MR, Schwaller B, et al. (1996) Change of calretinin expression in the human colon adenocarcinoma cell line HT29 after differentaition. Biochim Biophys Acta 1313:201–208

    Article  PubMed  Google Scholar 

  24. Taliano RJ, Lu S, Singh K, et al. (2013) Calretinin expression in high-grade invasive ductal carcinoma of the breast is associated with basal-like subtype and unfavorable prognosis. Hum Pathol 44(12):2743–2750

    Article  CAS  PubMed  Google Scholar 

  25. Gotzos V, Wintergerst ES, Musy JP, et al. (1999) Selective distribution of calretinin in adenocarcinomas of the human colon and adjacent tissues. Am J Surg Pathol 23:701–711

    Article  CAS  PubMed  Google Scholar 

  26. Purdie CA, Piris J (2000) Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma. Histopathol 36:121–126

    Article  CAS  Google Scholar 

  27. Niv Y (2000) Mucin and colorectal cancer. IMAJ 2:775–777

    CAS  PubMed  Google Scholar 

  28. Kahn HJ, Marks A (2002) A new monoclonal antibody, D2–40, for detection of lymphatic invasion in primary tumors. Lab Invest 82:1255–1257

    Article  PubMed  Google Scholar 

  29. Raica M, Cimpean AM, Ribatti D (2008) The Role of podoplanin in tumor progression and metastasis. Anticancer Res 28:2997–3006

    PubMed  Google Scholar 

  30. Kawamata F, Homma S, Kamachi H, et al. (2014) C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma. J Gastroenterol 49:81–92

    Article  CAS  PubMed  Google Scholar 

  31. Liebig B, Brabletz T, Staege MS, et al. (2005) Forced expression of deltaN-TCF-1B in colon cancer derived cell lines is accompanied by the induction of CEACAM5/6 and mesothelin. Cancer Lett 223:159–167

    Article  CAS  PubMed  Google Scholar 

  32. Foda AA, El-Hawary AK, Aziz AA (2015) Colorectal adenocarcinoma with mucinous component: relation of MMP-13, EGFR, and E-cadherin expressions to clinicopathological features and prognosis. APMIS. doi:10.1111/apm.12379

    PubMed  Google Scholar 

  33. Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, et al. (2009) Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 69:4116–4124

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Zhu QC, Gao RY, Wu W, et al. (2013) Epithelial-mesenchymal Transition and Its Role in the Pathogenesis of Colorectal Cancer. Asian Pacific J Cancer Prev 14(5):2689–2698

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Faculty of Medicine, Mansoura University, Mansoura, 35516, Egypt

    Abd AlRahman Mohammad Foda, Amira Kamal El-Hawary & Hazem Hamed

Authors
  1. Abd AlRahman Mohammad Foda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amira Kamal El-Hawary
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hazem Hamed
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amira Kamal El-Hawary.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Funding

The authors don’t have any financial interests with any of the commercial products mentioned in this article.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Foda, A.A.M., El-Hawary, A.K. & Hamed, H. Aberrant Expression of Calretinin, D2–40 and Mesothelin in Mucinous and Non-Mucinous Colorectal Carcinomas and Relation to Clinicopathological Features and Prognosis. Pathol. Oncol. Res. 22, 725–732 (2016). https://doi.org/10.1007/s12253-016-0060-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-016-0060-y

Keywords

Search

Navigation